SPI-C, a PU-box binding ETS protein expressed temporarily during B-cell development and in macrophages, contains an acidic transactivation domain located to the N-terminus

Molecular Immunology

Volumn 39, Issue 16, 2003, Pages 1035-1043

  Carlsson, Robert ^a   Persson, Christine ^a,b   Leanderson, Tomas ^a  

^a LUND UNIVERSITY   (Sweden)

^b Active Biotech Research AB   (Sweden)

Author keywords

His tag; Modular; PU.1; Substitution; Transcription

Indexed keywords

ASPARTIC ACID; IMMUNOGLOBULIN LAMBDA CHAIN; PROTEIN; PROTEIN SPI C; PURINE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL MATURATION; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; DNA BINDING; HUMAN; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; T LYMPHOCYTE; TRANSACTIVATION; TRANSCRIPTION REGULATION;

EID: 0038056175     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(03)00032-4     Document Type: Article

References (33)

1. Anderson M.K., Sun X., Miracle A.L., Litman G.W., Rothenberg E.V. Evolution of hematopoiesis: three members of the PU.1 transcription factor family in a cartilaginous fish, Raja eglanteria. Proc. Natl. Acad. Sci. U.S.A. 98:2001;553-558.
2. Bemark M., Martensson A., Liberg D., Leanderson T. Spi-C, a novel Ets protein that is temporally regulated during B lymphocyte development. J. Biol. Chem. 274:1999;10259-10267.
3. Carlsson R., Hjalmarsson A., Liberg D., Persson C., Leanderson T. Genomic structure of mouse SPI-C and genomic structure and expression pattern of human SPI-C. Gene. 299:2002;271-278.
4. Cress W.D., Triezenberg S.J. Critical structural elements of the VP16 transcriptional activation domain. Science. 251:1991;87-90.
5. DeKoter R.P., Singh H. Regulation of B lymphocyte and macrophage development by graded expression of PU.1. Science. 288:2000;1439-1441.
6. Eisenbeis C.F., Singh H., Storb U. PU.1 is a component of a multiprotein complex which binds an essential site in the murine immunoglobulin lambda 2-4 enhancer. Mol. Cell Biol. 13:1993;6452-6461.
7. Eisenbeis C.F., Singh H., Storb U. Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. Genes Dev. 9:1995;1377-1387.
8. Galson D.L., Hensold J.O., Bishop T.R., Schalling M., D'Andrea A.D., Jones C., Auron P.E., Housman D.E. Mouse beta-globin DNA-binding protein B1 is identical to a proto-oncogene, the transcription factor Spi-1/PU.1, and is restricted in expression to hematopoietic cells and the testis. Mol. Cell Biol. 13:1993;2929-2941.
9. Hashimoto S., Nishizumi H., Hayashi R., Tsuboi A., Nagawa F., Takemori T., Sakano H. Prf, a novel Ets family protein that binds to the PU.1 binding motif, is specifically expressed in restricted stages of B cell development. Int. Immunol. 11:1999;1423-1429.
10. Himmelmann A., Riva A., Wilson G.L., Lucas B.P., Thevenin C., Kehrl J.H. PU.1/Pip and basic helix loop helix zipper transcription factors interact with binding sites in the CD20 promoter to help confer lineage- and stage-specific expression of CD20 in B lymphocytes. Blood. 90:1997;3984-3995.
11. Karim F.D., Urness L.D., Thummel C.S., Klemsz M.J., McKercher S.R., Celada A., Van Beveren C., Maki R.A., Gunther C.V., Nye J.A.et al. The ETS-domain: a new DNA-binding motif that recognizes a purine-rich core DNA sequence. Genes Dev. 4:1990;1451-1453.
12. Klemsz M.J., Maki R.A. Activation of transcription by PU.1 requires both acidic and glutamine domains. Mol. Cell Biol. 16:1996;390-397.
13. Klemsz M.J., McKercher S.R., Celada A., Van Beveren C., Maki R.A. The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene. Cell. 61:1990;113-124.
14. Li S.L., Schlegel W., Valente A.J., Clark R.A. Critical flanking sequences of PU.1 binding sites in myeloid-specific promoters. J. Biol. Chem. 274:1999;32453-32460.
15. Mao C., Ray-Gallet D., Tavitian A., Moreau-Gachelin F. Differential phosphorylations of Spi-B and Spi-1 transcription factors. Oncogene. 12:1996;863-873.
16. McKercher S.R., Torbett B.E., Anderson K.L., Henkel G.W., Vestal D.J., Baribault H., Klemsz M., Feeney A.J., Wu G.E., Paige C.J., Maki R.A. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO. J. 15:1996;5647-5658.
17. Mittrucker H.W., Matsuyama T., Grossman A., Kundig T.M., Potter J., Shahinian A., Wakeham A., Patterson B., Ohashi P.S., Mak T.W. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science. 275:1997;540-543.
18. Pongubala J.M., Atchison M.L. PU.1 can participate in an active enhancer complex without its transcriptional activation domain. Proc. Natl. Acad. Sci. U.S.A. 94:1997;127-132.
19. Pongubala J.M., Nagulapalli S., Klemsz M.J., McKercher S.R., Maki R.A., Atchison M.L. PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3′ enhancer activity. Mol. Cell Biol. 12:1992;368-378.
20. Pongubala J.M., Van Beveren C., Nagulapalli S., Klemsz M.J., McKercher S.R., Maki R.A., Atchison M.L. Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation. Science. 259:1993;1622-1625.
21. Rao S., Garrett-Sinha L.A., Yoon J., Simon M.C. The Ets factors PU.1 and Spi-B regulate the transcription in vivo of P2Y10, a lymphoid restricted heptahelical receptor. J. Biol. Chem. 274:1999a;34245-34252.
22. Rao S., Matsumura A., Yoon J., Simon M.C. SPI-B activates transcription via a unique proline, serine, and threonine domain and exhibits DNA binding affinity differences from PU.1. J. Biol. Chem. 274:1999b;11115-11124.
23. Ray D., Bosselut R., Ghysdael J., Mattei M.G., Tavitian A., Moreau-Gachelin F. Characterization of Spi-B, a transcription factor related to the putative oncoprotein Spi-1/PU.1. Mol. Cell Biol. 12:1992;4297-4304.
24. Ray-Gallet D., Moreau-Gachelin F. Phosphorylation of the Spi-B transcription factor reduces its intrinsic stability. FEBS Lett. 464:1999;164-168.
25. Rieske P., Pongubala J.M. AKT induces transcriptional activity of PU.1 through phosphorylation-mediated modifications within its transactivation domain. J. Biol. Chem. 276:2001;8460-8468.
26. Sambrook, J.F.E.F., Maniatis, T., 1989. Molecular Cloning: A Laboratory Manual. Cold Spring Harbour, New York.
27. Schotte R., Rissoan M.C., Bendriss-Vermare N., Bridon J.M., Duhen T., Weijer K., Briere F., Spits H. The transcription factor Spi-B is expressed in plasmacytoid DC precursors and inhibits T-, B-, and NK-cell development. Blood. 101:2003;1015-1023.
28. Schreiber E., Matthias P., Muller M.M., Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 17:1989;6419.
29. Scott E.W., Simon M.C., Anastasi J., Singh H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science. 265:1994;1573-1577.
30. Sharrocks A.D. The ETS-domain transcription factor family. Nat. Rev. Mol. Cell Biol. 2:2001;827-837.
31. Su G.H., Ip H.S., Cobb B.S., Lu M.M., Chen H.M., Simon M.C. The Ets protein Spi-B is expressed exclusively in B cells and T cells during development. J. Exp. Med. 184:1996;203-214.
32. Su G.H., Chen H.M., Muthusamy N., Garrett-Sinha L.A., Baunoch D., Tenen D.G., Simon M.C. Defective B cell receptor-mediated responses in mice lacking the Ets protein, Spi-B. EMBO J. 16:1997;7118-7129.
33. Szymczyna B.R., Arrowsmith C.H. DNA binding specificity studies of four ETS proteins support an indirect read-out mechanism of protein-DNA recognition. J. Biol. Chem. 275:2000;28363-28370.